Home > Research > Publications & Outputs > Interleukin-17A Triggers the Release of Platele...

Links

Text available via DOI:

View graph of relations

Interleukin-17A Triggers the Release of Platelet-Derived Factors Driving Vascular Endothelial Cells toward a Pro-Angiogenic State

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Interleukin-17A Triggers the Release of Platelet-Derived Factors Driving Vascular Endothelial Cells toward a Pro-Angiogenic State. / Gatsiou, Aikaterini; Sopova, Kateryna; Tselepis, Alexandros et al.
In: Cells, Vol. 10, No. 8, 1855, 22.07.2021.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Gatsiou A, Sopova K, Tselepis A, Stellos K. Interleukin-17A Triggers the Release of Platelet-Derived Factors Driving Vascular Endothelial Cells toward a Pro-Angiogenic State. Cells. 2021 Jul 22;10(8):1855. doi: 10.3390/cells10081855

Author

Bibtex

@article{ac590d7a1a9949a49f73dabe2a0d9e9b,
title = "Interleukin-17A Triggers the Release of Platelet-Derived Factors Driving Vascular Endothelial Cells toward a Pro-Angiogenic State",
abstract = "Platelets comprise a highly interactive immune cell subset of the circulatory system traditionally known for their unique haemostatic properties. Although platelets are considered as a vault of growth factors, cytokines and chemokines with pivotal role in vascular regeneration and angiogenesis, the exact mechanisms by which they influence vascular endothelial cells (ECs) function remain underappreciated. In the present study, we examined the role of human IL-17A/IL-17RA axis in platelet-mediated pro-angiogenic responses. We reveal that IL-17A receptor (IL-17RA) mRNA is present in platelets transcriptome and a profound increase is documented on the surface of activated platelets. By quantifying the protein levels of several factors, involved in angiogenesis, we identified that IL-17A/IL17RA axis selectively induces the release of vascular endothelial growth factor, interleukin -2 and -4, as well as monocyte chemoattractant protein -1 from treated platelets. However, IL-17A exerted no effect on the release of IL-10, an anti-inflammatory factor with potentially anti-angiogenic properties, from platelets. Treatment of human endothelial cell two-dimensional tubule networks or three-dimensional spheroid and mouse aortic ring structures with IL-17A-induced platelet releasate evoked pro-angiogenic responses of ECs. Our findings suggest that IL-17A may critically affect platelet release of pro-angiogenic factors driving ECs towards a pro-angiogenic state.",
keywords = "Angiogenic Proteins/metabolism, Animals, Blood Platelets/drug effects, Cell Movement, Cell Proliferation, Cells, Cultured, Human Umbilical Vein Endothelial Cells/metabolism, Humans, Inflammation Mediators/metabolism, Interleukin-17/pharmacology, Mice, Inbred C57BL, Neovascularization, Physiologic, Paracrine Communication, Phenotype, Platelet Activation/drug effects, Receptors, Interleukin-17/agonists, Signal Transduction, Mice",
author = "Aikaterini Gatsiou and Kateryna Sopova and Alexandros Tselepis and Konstantinos Stellos",
year = "2021",
month = jul,
day = "22",
doi = "10.3390/cells10081855",
language = "English",
volume = "10",
journal = "Cells",
issn = "2073-4409",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "8",

}

RIS

TY - JOUR

T1 - Interleukin-17A Triggers the Release of Platelet-Derived Factors Driving Vascular Endothelial Cells toward a Pro-Angiogenic State

AU - Gatsiou, Aikaterini

AU - Sopova, Kateryna

AU - Tselepis, Alexandros

AU - Stellos, Konstantinos

PY - 2021/7/22

Y1 - 2021/7/22

N2 - Platelets comprise a highly interactive immune cell subset of the circulatory system traditionally known for their unique haemostatic properties. Although platelets are considered as a vault of growth factors, cytokines and chemokines with pivotal role in vascular regeneration and angiogenesis, the exact mechanisms by which they influence vascular endothelial cells (ECs) function remain underappreciated. In the present study, we examined the role of human IL-17A/IL-17RA axis in platelet-mediated pro-angiogenic responses. We reveal that IL-17A receptor (IL-17RA) mRNA is present in platelets transcriptome and a profound increase is documented on the surface of activated platelets. By quantifying the protein levels of several factors, involved in angiogenesis, we identified that IL-17A/IL17RA axis selectively induces the release of vascular endothelial growth factor, interleukin -2 and -4, as well as monocyte chemoattractant protein -1 from treated platelets. However, IL-17A exerted no effect on the release of IL-10, an anti-inflammatory factor with potentially anti-angiogenic properties, from platelets. Treatment of human endothelial cell two-dimensional tubule networks or three-dimensional spheroid and mouse aortic ring structures with IL-17A-induced platelet releasate evoked pro-angiogenic responses of ECs. Our findings suggest that IL-17A may critically affect platelet release of pro-angiogenic factors driving ECs towards a pro-angiogenic state.

AB - Platelets comprise a highly interactive immune cell subset of the circulatory system traditionally known for their unique haemostatic properties. Although platelets are considered as a vault of growth factors, cytokines and chemokines with pivotal role in vascular regeneration and angiogenesis, the exact mechanisms by which they influence vascular endothelial cells (ECs) function remain underappreciated. In the present study, we examined the role of human IL-17A/IL-17RA axis in platelet-mediated pro-angiogenic responses. We reveal that IL-17A receptor (IL-17RA) mRNA is present in platelets transcriptome and a profound increase is documented on the surface of activated platelets. By quantifying the protein levels of several factors, involved in angiogenesis, we identified that IL-17A/IL17RA axis selectively induces the release of vascular endothelial growth factor, interleukin -2 and -4, as well as monocyte chemoattractant protein -1 from treated platelets. However, IL-17A exerted no effect on the release of IL-10, an anti-inflammatory factor with potentially anti-angiogenic properties, from platelets. Treatment of human endothelial cell two-dimensional tubule networks or three-dimensional spheroid and mouse aortic ring structures with IL-17A-induced platelet releasate evoked pro-angiogenic responses of ECs. Our findings suggest that IL-17A may critically affect platelet release of pro-angiogenic factors driving ECs towards a pro-angiogenic state.

KW - Angiogenic Proteins/metabolism

KW - Animals

KW - Blood Platelets/drug effects

KW - Cell Movement

KW - Cell Proliferation

KW - Cells, Cultured

KW - Human Umbilical Vein Endothelial Cells/metabolism

KW - Humans

KW - Inflammation Mediators/metabolism

KW - Interleukin-17/pharmacology

KW - Mice, Inbred C57BL

KW - Neovascularization, Physiologic

KW - Paracrine Communication

KW - Phenotype

KW - Platelet Activation/drug effects

KW - Receptors, Interleukin-17/agonists

KW - Signal Transduction

KW - Mice

U2 - 10.3390/cells10081855

DO - 10.3390/cells10081855

M3 - Journal article

C2 - 34440624

VL - 10

JO - Cells

JF - Cells

SN - 2073-4409

IS - 8

M1 - 1855

ER -